MeSH term
Frequency | Condition_Probility | Female | 5 | 0.0 |
Humans | 31 | 0.0 |
Animals | 22 | 0.0 |
*Apoptosis | 8 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Membrane Proteins/metabolism | 2 | 0.0 |
Necrosis | 4 | 1.0 |
Proteins/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/metabolism | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 31 | 0.0 |
Apoptosis | 6 | 0.0 |
Cytochrome c Group/metabolism | 2 | 1.0 |
Membrane Proteins/genetics/*metabolism | 3 | 1.0 |
*Proto-Oncogene Proteins | 18 | 1.0 |
Rats | 8 | 0.0 |
*Tumor Suppressor Proteins | 22 | 1.0 |
Cell Line | 5 | 0.0 |
Membrane Proteins/*genetics | 3 | 0.0 |
Mice | 10 | 0.0 |
Mice, Knockout | 3 | 0.0 |
Nitric Oxide/*metabolism | 2 | 1.0 |
Promoter Regions (Genetics)/genetics | 2 | 0.0 |
Proto-Oncogene Proteins/*genetics | 2 | 0.0 |
S-Nitroso-N-Acetylpenicillamine/pharmacology | 2 | 28.0 |
Amino Acid Sequence | 6 | 0.0 |
Apoptosis/*physiology | 4 | 0.0 |
Cells, Cultured | 11 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Transfection | 6 | 0.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Blotting, Western | 6 | 0.0 |
Cell Survival | 2 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
*Gene Expression Regulation | 3 | 0.0 |
Male | 3 | 0.0 |
Proto-Oncogene Proteins c-bcl-2/*metabolism | 3 | 1.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Rats, Sprague-Dawley | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 11 | 0.0 |
Signal Transduction | 5 | 0.0 |
Time Factors | 3 | 0.0 |
Up-Regulation | 4 | 0.0 |
Breast Neoplasms/genetics/metabolism | 2 | 4.0 |
CHO Cells | 2 | 0.0 |
Hamsters | 3 | 0.0 |
Membrane Proteins/*biosynthesis/genetics | 2 | 5.0 |
Oligonucleotide Array Sequence Analysis | 9 | 0.0 |
*Transcription Factors | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Cell Hypoxia | 4 | 2.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Mitochondria/metabolism | 3 | 1.0 |
Comparative Study | 5 | 0.0 |
*Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Dimerization | 3 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Subcellular Fractions/metabolism | 5 | 1.0 |
Membrane Proteins/genetics | 2 | 0.0 |
Permeability | 2 | 1.0 |
Reactive Oxygen Species/metabolism | 2 | 0.0 |
Fibroblasts | 2 | 0.0 |
beta-Galactosidase/metabolism | 2 | 1.0 |
Cell Line, Tumor | 3 | 0.0 |
COS Cells | 3 | 0.0 |
Mitochondria/*metabolism | 3 | 1.0 |
Mutation | 3 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
*Gene Expression Profiling | 3 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
Antineoplastic Agents/*pharmacology | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Cell Nucleus/*metabolism | 2 | 0.0 |
Immunohistochemistry/methods | 2 | 0.0 |
Adult | 2 | 0.0 |
Genes, Reporter | 2 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
*Anoxia | 2 | 7.0 |
Oligonucleotides, Antisense/pharmacology | 2 | 0.0 |
Intracellular Membranes/metabolism | 2 | 1.0 |
